Just how worried should you be about the delta variant? Advisory Board's Yulan Egan takes a deep dive into this question, detailing seven factors you should watch closely (and two to ignore) to determine just how deadly and disruptive the variant will prove to be.
Writing for Harvard Business Review, Nikhil Bhojwani and Deborah Lovich outline six principles to help you plan how to reopen your office—even as the delta variant puts many reopening plans on hold.
Vaccines can dramatically cut the risk of coronavirus infection—even among people who've already had Covid-19, according to a small, real-world study in CDC's Morbidity and Mortality Weekly Report.
As students prepare to return to school in the fall, the White House on Thursday unveiled a new initiative aimed at increasing the lagging Covid-19 vaccination rates among young people, Sheryl Gay Stolberg reports for the New York Times.
Several studies suggest a correlation between receiving common vaccines, including those against diptheria/tetanus and influenza, and a reduced risk of Alzheimer's disease, Allysia Finley reports for the Wall Street Journal. Here's what the evidence shows so far—and what the implications could be for Covid-19 vaccines.
Rep. Ralph Norman is the second lawmaker to test positive for the coronavirus despite vaccination, in today's bite-sized hospital and health industry news from California, the District of Columbia, and Georgia.
